This meta‐analysis highlights that once‐weekly basal insulin Fc provides comparable glycaemic control to daily insulin degludec but is associated with higher rates of clinically significant and severe hypoglycaemia, particularly in type 1 diabetes and insulin‐experienced patients. The gene discussed is INS; the disease is type 1 diabetes mellitus.